Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent
Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages…
Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent
Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. The companies project these drugs will start reaching pivotal testing in 2029 — important because Dupixent faces patent expiration in 2031. The post Sanofi Puts Up $1B to Expand…
How Penn Medicine Investigates Improper Patient Record Access
Privacy Officer John Nocito describes his three-person team’s use of technology and disciplined processes to investigate potential cases of inappropriate access by employees
The Average Medicare Beneficiary has 28 Medicare Advantage Prescription Drug Plan Options for 2027
The average Medicare beneficiary will have 28 Medicare Advantage prescription drug (MA_PD) plans available for general enrollment in 2027. The number of plans varies widely across states.
The Real Gap in All of Us Isn’t Consent, It’s Conversion
Why more than 300,000 missing patient records reveal an engineering problem, not a policy one — and why that’s good news. The post The Real Gap in All of Us Isn’t Consent, It’s Conversion appeared first on MedCity News.
How Is The Federal Government Counting Measles Deaths?
Recently Secretary of HHS Robert F. Kennedy, Jr., changed how the federal government tracks deaths in its official measles tally, after Pennsylvania reported four deaths. This Policy Watch reviews the two roles, strengths, and weaknesses of the two public health surveillance systems at the center of this change: the Nationally Notifiable Diseases Surveillance System (NNDSS)…
Listen to the Latest ‘KFF Health News Minute’
The KFF Health News Minute is available every Thursday via direct download or the RSS feed. Oct. 1 Arielle Zionts [arr-ee-ELL ZY-ence] reads the week’s news: If you’re an older patient taking a long list of medications, consider reviewing them with a primary care provider to make sure they’re helping more than hurting. Plus, states are…
Healthcare Is Scary. Channel Your Fears Into a Haiku.
(Oona Zenda/KFF Health News) Something wicked this way comes, and it’s 5-7-5. Our annual Halloween haiku contest is back, and we’re once again summoning readers to turn the horrors of healthcare into three tiny lines of poetry. Surprise us with a verse about medical bills, insurance, hospitals, health policy, or whatever else keeps you up…
Hospitals Have a Little-Known Tool To Prevent Medical Debt. Here’s How It Works.
If you have medical debt, there’s a good chance you owe money to a hospital. One way patients can avoid medical debt is through hospital financial assistance, also known as charity care. Most of the nation’s hospitals offer free or discounted medical care to patients with very high medical debt or low incomes. Getting financial…
The Least-Informed Person in the Room
By DAVID KIRK My father called me from a hospital bed a few years ago. He had been admitted to a small hospital with an abdominal infection, and his surgeon had offered him an open operation. He wanted my clinical perspective. I knew that in his condition, he was unlikely to survive general anesthesia and…
FDA Looks to Bring New Scientific, Consumer Voices to Advisory Committees
The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have met less frequently during the Trump administration, more meetings have been scheduled since former Commissioner Marty Makary left the agency in May. The post FDA Looks to Bring New Scientific, Consumer Voices to Advisory Committees appeared…
